JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lemberger, T.
Right arrow Articles by Wahli, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lemberger, T.
Right arrow Articles by Wahli, W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 269, Issue 40, 24527-24530, 10, 1994

Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids

T Lemberger, B Staels, R Saladin, B Desvergne, J Auwerx and W Wahli
Institut de Biologie Animale, Batiment de Biologie, Universite de Lausanne, Switzerland.

This study demonstrates that the expression of the peroxisome proliferator-activated receptor alpha (PPAR alpha) is regulated by glucocorticoid hormones in hepatocytes. Hydrocortisone, dexamethasone, and triamcinolone stimulated PPAR alpha mRNA synthesis in a dose- dependent manner in primary rat hepatocyte cultures. This glucocorticoid stimulation was inhibited by RU 486, a specific glucocorticoid antagonist. Moreover, in contrast to glucocorticoid hormones, the mineralocorticoid aldosterone had only a weak effect, suggesting that the hormonal stimulation of PPAR alpha was mediated by the glucocorticoid receptor. The induction was not prevented by cycloheximide treatment of the hepatocytes, indicating that it was mediated by preexisting glucocorticoid receptor. Finally, the RNA synthesis inhibitor actinomycin D abolished the stimulatory effect of dexamethasone, and nuclear run-on analysis showed an increase of PPAR alpha transcripts after hormonal induction. Thus, the PPAR alpha gene is an early response gene of glucocorticoids that control its expression at the transcriptional level.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
B. Manmontri, M. Sariahmetoglu, J. Donkor, M. B. Khalil, M. Sundaram, Z. Yao, K. Reue, R. Lehner, and D. N. Brindley
Glucocorticoids and cyclic AMP selectively increase hepatic lipin-1 expression, and insulin acts antagonistically
J. Lipid Res., May 1, 2008; 49(5): 1056 - 1067.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. Garcia-Bueno, J. L. M. Madrigal, B. G. Perez-Nievas, and J. C. Leza
Stress Mediators Regulate Brain Prostaglandin Synthesis and Peroxisome Proliferator-Activated Receptor-{gamma} Activation after Stress in Rats
Endocrinology, April 1, 2008; 149(4): 1969 - 1978.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Cuzzocrea, S. Bruscoli, E. Mazzon, C. Crisafulli, V. Donato, R. Di Paola, E. Velardi, E. Esposito, G. Nocentini, and C. Riccardi
Peroxisome Proliferator-Activated Receptor-{alpha} Contributes to the Anti-Inflammatory Activity of Glucocorticoids
Mol. Pharmacol., February 1, 2008; 73(2): 323 - 337.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. Qi and B. Rodrigues
Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism
Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E654 - E667.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
V. D YUMUK
Targeting Components of the Stress System as Potential Therapies for the Metabolic Syndrome: The Peroxisome-Proliferator-Activated Receptors
Ann. N.Y. Acad. Sci., November 1, 2006; 1083(1): 306 - 318.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. Canaple, J. Rambaud, O. Dkhissi-Benyahya, B. Rayet, N. S. Tan, L. Michalik, F. Delaunay, W. Wahli, and V. Laudet
Reciprocal Regulation of Brain and Muscle Arnt-Like Protein 1 and Peroxisome Proliferator-Activated Receptor {alpha} Defines a Novel Positive Feedback Loop in the Rodent Liver Circadian Clock
Mol. Endocrinol., August 1, 2006; 20(8): 1715 - 1727.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. Nadra, S. I. Anghel, E. Joye, N. S. Tan, S. Basu-Modak, D. Trono, W. Wahli, and B. Desvergne
Differentiation of Trophoblast Giant Cells and Their Metabolic Functions Are Dependent on Peroxisome Proliferator-Activated Receptor {beta}/{delta}
Mol. Cell. Biol., April 15, 2006; 26(8): 3266 - 3281.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. A. Lillycrop, E. S. Phillips, A. A. Jackson, M. A. Hanson, and G. C. Burdge
Dietary Protein Restriction of Pregnant Rats Induces and Folic Acid Supplementation Prevents Epigenetic Modification of Hepatic Gene Expression in the Offspring
J. Nutr., June 1, 2005; 135(6): 1382 - 1386.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. Mouthiers, A. Baillet, C. Delomenie, D. Porquet, and N. Mejdoubi-Charef
Peroxisome Proliferator-Activated Receptor {alpha} Physically Interacts with CCAAT/Enhancer Binding Protein (C/EBP{beta}) to Inhibit C/EBP{beta}-Responsive {alpha}1-Acid Glycoprotein Gene Expression
Mol. Endocrinol., May 1, 2005; 19(5): 1135 - 1146.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. R. Stayrook, K. S. Bramlett, R. S. Savkur, J. Ficorilli, T. Cook, M. E. Christe, L. F. Michael, and T. P. Burris
Regulation of Carbohydrate Metabolism by the Farnesoid X Receptor
Endocrinology, March 1, 2005; 146(3): 984 - 991.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. M. Paterson, N. M. Morton, C. Fievet, C. J. Kenyon, M. C. Holmes, B. Staels, J. R. Seckl, and J. J. Mullins
Metabolic syndrome without obesity: Hepatic overexpression of 11{beta}-hydroxysteroid dehydrogenase type 1 in transgenic mice
PNAS, May 4, 2004; 101(18): 7088 - 7093.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. Olsson, M. Bohlooly-Y, O. Brusehed, O. G. P. Isaksson, B. Ahren, S.-O. Olofsson, J. Oscarsson, and J. Tornell
Bovine growth hormone-transgenic mice have major alterations in hepatic expression of metabolic genes
Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E504 - E511.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
I. Pineda Torra, T. Claudel, C. Duval, V. Kosykh, J.-C. Fruchart, and B. Staels
Bile Acids Induce the Expression of the Human Peroxisome Proliferator-Activated Receptor {alpha} Gene via Activation of the Farnesoid X Receptor
Mol. Endocrinol., February 1, 2003; 17(2): 259 - 272.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. D. Wheeler, O. M. Smutney, J. F. Check, I. Rusyn, R. Schulte-Hermann, and R. G. Thurman
Impaired Ras membrane association and activation in PPARalpha knockout mice after partial hepatectomy
Am J Physiol Gastrointest Liver Physiol, February 1, 2003; 284(2): G302 - G312.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Jalouli, L. Carlsson, C. Ameen, D. Linden, A. Ljungberg, L. Michalik, S. Eden, W. Wahli, and J. Oscarsson
Sex Difference in Hepatic Peroxisome Proliferator-Activated Receptor {alpha} Expression: Influence of Pituitary and Gonadal Hormones
Endocrinology, January 1, 2003; 144(1): 101 - 109.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. M. Pascussi, M. Busson-Le Coniat, P. Maurel, and M.-J. Vilarem
Transcriptional Analysis of the Orphan Nuclear Receptor Constitutive Androstane Receptor (NR1I3) Gene Promoter: Identification of a Distal Glucocorticoid Response Element
Mol. Endocrinol., January 1, 2003; 17(1): 42 - 55.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
N.-S. Tan, N. S. Shaw, N. Vinckenbosch, P. Liu, R. Yasmin, B. Desvergne, W. Wahli, and N. Noy
Selective Cooperation between Fatty Acid Binding Proteins and Peroxisome Proliferator-Activated Receptors in Regulating Transcription
Mol. Cell. Biol., July 15, 2002; 22(14): 5114 - 5127.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
I. Pineda Torra, Y. Jamshidi, D. M. Flavell, J.-C. Fruchart, and B. Staels
Characterization of the Human PPAR{alpha} Promoter: Identification of a Functional Nuclear Receptor Response Element
Mol. Endocrinol., May 1, 2002; 16(5): 1013 - 1028.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
O. Barbier, I. P. Torra, Y. Duguay, C. Blanquart, J.-C. Fruchart, C. Glineur, and B. Staels
Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors in Lipid Metabolism and Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., May 1, 2002; 22(5): 717 - 726.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. R. Shepard, N. Jacobson, J. H. Fingert, E. M. Stone, V. C. Sheffield, and A. F. Clark
Delayed Secondary Glucocorticoid Responsiveness of MYOC in Human Trabecular Meshwork Cells
Invest. Ophthalmol. Vis. Sci., December 1, 2001; 42(13): 3173 - 3181.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. I. Trickett, D. D. Patel, B. L. Knight, E. D. Saggerson, G. F. Gibbons, and R. J. Pease
Characterization of the Rodent Genes for Arylacetamide Deacetylase, a Putative Microsomal Lipase, and Evidence for Transcriptional Regulation
J. Biol. Chem., October 19, 2001; 276(43): 39522 - 39532.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. Escher, O. Braissant, S. Basu-Modak, L. Michalik, W. Wahli, and B. Desvergne
Rat PPARs: Quantitative Analysis in Adult Rat Tissues and Regulation in Fasting and Refeeding
Endocrinology, October 1, 2001; 142(10): 4195 - 4202.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
L. Michalik, B. Desvergne, N. S. Tan, S. Basu-Modak, P. Escher, J. Rieusset, J. M. Peters, G. Kaya, F. J. Gonzalez, J. Zakany, et al.
Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR){alpha} and PPAR{beta} mutant mice
J. Cell Biol., August 20, 2001; 154(4): 799 - 814.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J.-M. Pascussi, S. Gerbal-Chaloin, J.-M. Fabre, P. Maurel, and M.-J. Vilarem
Dexamethasone Enhances Constitutive Androstane Receptor Expression in Human Hepatocytes: Consequences on Cytochrome P450 Gene Regulation
Mol. Pharmacol., April 13, 2001; 58(6): 1441 - 1450.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
D. D. Patel, B. L. Knight, D. Wiggins, S. M. Humphreys, and G. F. Gibbons
Disturbances in the normal regulation of SREBP-sensitive genes in PPAR{{alpha}}-deficient mice
J. Lipid Res., March 1, 2001; 42(3): 328 - 337.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
G. P. Hayhurst, Y.-H. Lee, G. Lambert, J. M. Ward, and F. J. Gonzalez
Hepatocyte Nuclear Factor 4{alpha} (Nuclear Receptor 2A1) Is Essential for Maintenance of Hepatic Gene Expression and Lipid Homeostasis
Mol. Cell. Biol., February 15, 2001; 21(4): 1393 - 1403.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
E. Falkenstein, H.-C. Tillmann, M. Christ, M. Feuring, and M. Wehling
Multiple Actions of Steroid Hormones---A Focus on Rapid, Nongenomic Effects
Pharmacol. Rev., December 1, 2000; 52(4): 513 - 556.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
I. P. Torra, V. Tsibulsky, F. Delaunay, R. Saladin, V. Laudet, J.-C. Fruchart, V. Kosykh, and B. Staels
Circadian and Glucocorticoid Regulation of Rev-erb{alpha} Expression in Liver
Endocrinology, October 1, 2000; 141(10): 3799 - 3806.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. P. Collett, A. M. Betts, M. I. Johnson, A. B. Pulimood, S. Cook, D. E. Neal, and C. N. Robson
Peroxisome Proliferator-activated Receptor {{alpha}} Is an Androgen-responsive Gene in Human Prostate and Is Highly Expressed in Prostatic Adenocarcinoma
Clin. Cancer Res., August 1, 2000; 6(8): 3241 - 3248.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
J. M. Peters, I. Rusyn, M. L. Rose, F. J. Gonzalez, and R. G. Thurman
Peroxisome proliferator-activated receptor {alpha} is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis
Carcinogenesis, April 1, 2000; 21(4): 823 - 826.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. M. Sapolsky, L. M. Romero, and A. U. Munck
How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions
Endocr. Rev., February 1, 2000; 21(1): 55 - 89.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. R. Sartippour and G. Renier
Differential Regulation of Macrophage Peroxisome Proliferator-Activated Receptor Expression by Glucose : Role of Peroxisome Proliferator-Activated Receptors in Lipoprotein Lipase Gene Expression
Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 104 - 110.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Basu-Modak, O. Braissant, P. Escher, B. Desvergne, P. Honegger, and W. Wahli
Peroxisome Proliferator-activated Receptor beta Regulates Acyl-CoA Synthetase 2 in Reaggregated Rat Brain Cell Cultures
J. Biol. Chem., December 10, 1999; 274(50): 35881 - 35888.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
B. Desvergne and W. Wahli
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism
Endocr. Rev., October 1, 1999; 20(5): 649 - 688.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
V. Giguère
Orphan Nuclear Receptors: From Gene to Function
Endocr. Rev., October 1, 1999; 20(5): 689 - 725.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
P. Gervois, I. P. Torra, G. Chinetti, T. Grötzinger, G. Dubois, J.-C. Fruchart, J. Fruchart-Najib, E. Leitersdorf, and B. Staels
A Truncated Human Peroxisome Proliferator-Activated Receptor {alpha} Splice Variant with Dominant Negative Activity
Mol. Endocrinol., September 1, 1999; 13(9): 1535 - 1549.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
T. E. Johnson, R. Vogel, S. J. Rutledge, G. Rodan, and A. Schmidt
Thiazolidinedione Effects on Glucocorticoid Receptor-Mediated Gene Transcription and Differentiation in Osteoblastic Cells
Endocrinology, July 1, 1999; 140(7): 3245 - 3254.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Y.-C. Zhou and D. J. Waxman
Cross-talk between Janus Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) and Peroxisome Proliferator-activated Receptor-alpha (PPARalpha ) Signaling Pathways. GROWTH HORMONE INHIBITION OF PPARalpha TRANSCRIPTIONAL ACTIVITY MEDIATED BY STAT5b
J. Biol. Chem., January 29, 1999; 274(5): 2672 - 2681.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Ellinghaus, C. Wolfrum, G. Assmann, F. Spener, and U. Seedorf
Phytanic Acid Activates the Peroxisome Proliferator-activated Receptor alpha  (PPARalpha ) in Sterol Carrier Protein 2-/ Sterol Carrier Protein x-deficient Mice
J. Biol. Chem., January 29, 1999; 274(5): 2766 - 2772.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. E. Poynter and R. A. Daynes
Peroxisome Proliferator-activated Receptor alpha  Activation Modulates Cellular Redox Status, Represses Nuclear Factor-kappa B Signaling, and Reduces Inflammatory Cytokine Production in Aging
J. Biol. Chem., December 4, 1998; 273(49): 32833 - 32841.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
O. Braissant and W. Wahli
Differential Expression of Peroxisome Proliferator-Activated Receptor-{alpha}, -{beta}, and -{gamma} during Rat Embryonic Development
Endocrinology, June 1, 1998; 139(6): 2748 - 2754.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
H. H. Steineger, B. M. Arntsen, O. Spydevold, and H. N. Sørensen
Gene transcription of the retinoid X receptor {alpha} (RXR{alpha}) is regulated by fatty acids and hormones in rat hepatic cells
J. Lipid Res., April 1, 1998; 39(4): 744 - 754.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
C. N. A. Palmer, M.-H. Hsu, K. J. Griffin, J. L. Raucy, and E. F. Johnson
Peroxisome Proliferator Activated Receptor-alpha Expression in Human Liver
Mol. Pharmacol., January 1, 1998; 53(1): 14 - 22.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. Schedin, P. J. Sindelar, P. Pentchev, U. Brunk, and G. Dallner
Peroxisomal Impairment in Niemann-Pick Type C Disease
J. Biol. Chem., March 7, 1997; 272(10): 6245 - 6251.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Gremlich, R. Roduit, and B. Thorens
Dexamethasone Induces Posttranslational Degradation of GLUT2 and Inhibition of Insulin Secretion in Isolated Pancreatic beta Cells. COMPARISON WITH THE EFFECTS OF FATTY ACIDS
J. Biol. Chem., February 7, 1997; 272(6): 3216 - 3222.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Gotoh, S. Chowdhury, M. Takiguchi, and M. Mori
The Glucocorticoid-responsive Gene Cascade. ACTIVATION OF THE RAT ARGINASE GENE THROUGH INDUCTION OF C/EBPbeta
J. Biol. Chem., February 7, 1997; 272(6): 3694 - 3698.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. J. Ledwith, C. J. Pauley, L. K. Wagner, C. L. Rokos, D. W. Alberts, and S. Manam
Induction of Cyclooxygenase-2 Expression by Peroxisome Proliferators and Non-tetradecanoylphorbol 12,13-Myristate-type Tumor Promoters in Immortalized Mouse Liver Cells
J. Biol. Chem., February 7, 1997; 272(6): 3707 - 3714.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Lemberger, Rég. Saladin, M. Vázquez, F.ço. Assimacopoulos, B. Staels, Béa. Desvergne, W. Wahli, and J. Auwerx
Expression of the Peroxisome Proliferator-activated Receptor alpha Gene Is Stimulated by Stress and Follows a Diurnal Rhythm
J. Biol. Chem., January 19, 1996; 271(3): 1764 - 1769.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
Z Wu, Y Xie, N L Bucher, and S R Farmer
Conditional ectopic expression of C/EBP beta in NIH-3T3 cells induces PPAR gamma and stimulates adipogenesis.
Genes & Dev., October 1, 1995; 9(19): 2350 - 2363.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
C. E. Juge-Aubry, A. Gorla-Bajszczak, A. Pernin, T. Lemberger, W. Wahli, A. G. Burger, and C. A. Meier
Peroxisome Proliferator-activated Receptor Mediates Cross-talk with Thyroid Hormone Receptor by Competition for Retinoid X Receptor
J. Biol. Chem., July 28, 1995; 270(30): 18117 - 18122.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. M. Morton, M. C. Holmes, C. Fievet, B. Staels, A. Tailleux, J. J. Mullins, and J. R. Seckl
Improved Lipid and Lipoprotein Profile, Hepatic Insulin Sensitivity, and Glucose Tolerance in 11beta -Hydroxysteroid Dehydrogenase Type 1 Null Mice
J. Biol. Chem., October 26, 2001; 276(44): 41293 - 41300.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. C. Jones, X. Ding, and R. A. Daynes
Nuclear Receptor Peroxisome Proliferator-activated Receptor alpha (PPARalpha ) Is Expressed in Resting Murine Lymphocytes. THE PPARalpha IN T AND B LYMPHOCYTES IS BOTH TRANSACTIVATION AND TRANSREPRESSION COMPETENT
J. Biol. Chem., February 22, 2002; 277(9): 6838 - 6845.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Y. Nagai, Y. Nishio, T. Nakamura, H. Maegawa, R. Kikkawa, and A. Kashiwagi
Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha
Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E1180 - E1190.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1994 by the American Society for Biochemistry and Molecular Biology.